| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dexcom, Inc. (DXCM) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. DXCM is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 331.7K | $19.43M | - | |
| VP | 118.7K | $6.95M | - | |
| VP | 111.2K | $6.51M | -1,700 | |
| VP | 105.2K | $6.16M | - | |
| VP | 68.7K | $4.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2022 | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 1,000 | $72.55 | $72,550.00 | -0.7% | +12.3% | +68.5% | |
| Jun 6, 2022 | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 600 | $301.57 | $180,942.00 | -3.3% | +10.7% | +69.2% | |
| May 24, 2022 | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 250 | $296.33 | $74,082.50 | -0.7% | +17.0% | +62.1% | |
| May 9, 2022 | Patterson Chad56 | EVP Global Marketing | Sell | 777 | $342.77 | $266,332.29 | -5.4% | +10.8% | +45.0% | |
| Apr 25, 2022 | Pacelli Steven Robert57 | Managing Dir., Dexcom Ventures | Sell | 250 | $439.94 | $109,985.00 | -0.7% | -25.3% | +12.1% | |
| Apr 11, 2022 | Patterson Chad56 | EVP, Global Marketing | Sell | 776 | $498.75 | $387,030.00 | -5.1% | -36.3% | -6.6% | |
| Mar 29, 2022 | Regan Barry J.60 | EVP Global Operations | Sell | 1,106 | $500.00 | $553,000.00 | -6.3% | -40.5% | -11.5% | |
| Mar 23, 2022 | Pacelli Steven Robert57 | Managing Dir., Dexcom Ventures | Sell | 250 | $459.98 | $114,995.00 | -0.7% | -37.3% | +1.9% | |
| Mar 17, 2022 | Dolan Matthew Vincent63 | SVP Corporate Development | Sell | 2,186 | $424.68 | $928,358.56 | -9.2% | -37.1% | +0.2% | |
| Mar 15, 2022 | Sayer Kevin R62 | Chairman, CEO &President | Sell | 3,000 | $409.77 | $1,229,295.05 | -0.3% | -34.6% | +9.3% |